Programme

Day 1 – 18.6. →

Day 2 – 19.6. →
Plenary Session 

Day 2 – 19.6.  →
Parallel Session 

Day 3 – 20.6. →

Day 1    Day 2 PLEN    Day 2 PARA    Day 3

Day 1 – 18.6.2024

9:00 - 9:20
9:20 - 10:45
9:20 - 10:10
10:10 - 10:30
10:30 - 10:45
10:45 - 11:15
11:15 - 12:45
11:15 - 12:05
12:05 - 12:25
12:25 - 12:45
12:45 - 13:45
13:45 - 14:45
13:45 - 14:05
14:05 - 14:25
14:25 - 14:45
14:45 - 15:25
14:45 - 15:25
15:25 - 16:20
15:25 - 15:40
15:40 - 16:00
16:00 - 16:20
16:20 - 16:50
16:50 - 18:30
16:50 - 17:10
17:10 - 17:30
17:30 - 17:50
17:50 - 18:30
18:30
Panorama Hall
IPC2024: of Giants, Big Shoes and Great Expectations
Arthur C. Ouwehand, IFF, Finland
Metabolomic Session
A Gut Microbiota-Generated Metabolite as a Mediator of Healthy Aging
Dongryeol Ryu, Gwangju Institute of Science and Technology GIST, South Korea
Optimizing the Functionality of the Gut Microbiome
Alojz Bomba, Perbiotix, Slovakia
Neonatal Gut Microbial Propionate Can Prevent Subsequent Onset of Bronchial Asthmatic Inflammation
Hiroshi Ohno, RIKEN Center for Integrative Medical Sciences, Japan
Coffee Break
Next Gen Probiotics
Engineering Tumor-colonizing E. coli Nissle 1917 for Detection and Treatment of Colorectal Neoplasia
Susan Lesley Woods, University of Adelaide- Australia, Adelaide Medical School, Australia
Potential Use of Probiotic Strain of Escherichia coli O83:K24:H31 to Prevent Colitis Development
Jiří Hrdý, First Faculty of Medicine, Charles University, Czechia
The Benefits, Strategy, and Challenges of Using Genetic Engineering for Product Development
Bentley Shuster, Zbiotics, New York, USA
Lunch Break
Next Gen Probiotics
Enabling Technologies for Precise Engineering of Probiotics & Starter Cultures: How to Cover the Full Range from NonGMO to GMO
Claudia Borgmeier, BRAIN Biotech AG, Germany BRAIN AG, R&D, Germany
Next Generation Probiotics: from Sample Collection to Candidate Strain
Arthur Ouwehand, IFF, Finland
Akkermansia muciniphila: A Star Player in Next-Gen Probiotics
Rishi Trivedi
Phages
Bacteriophages: It’s a Medicine, Jim, but Not as We Know It
Jean-Paul Pirnay, Queen Astrid Military Hospital, Laboratory for Molecular and Cellular Technology, Belgium
Simulating and modeling: Gut and other organs, body parts, organoids
Potential Use of Sodium Alginate as a Coating Material for Next-generation Probiotics
Thi Thanh Truc Phung, L'Institut Agro Dijon, Laboratory UMR-PAM, France
Gut Bioengineered Models to Study Host-microbiome Direct Interactions
Catherine Daniel, Institut Pasteur de Lille, France
In Vitro Models of Inflammation-damaged Intestinal Mucosa for Screening the Efficacy of Probiotic Strains
Jana Štofilova, Pavol Jozef Šafárik University in Košice- Faculty of Medicine, Slovakia
Coffee Break
AI in Probiotic Research
The Effects of Human Milk Oligosaccharides and Bifidobacterium Longum Subsp. Infantis, Bifin02TM, on the Infant Gut Microbiome Composition and Function in an Infant in Vitro Colonic Model, I-TIM-2
Olivia Colberg, Novonesis, Denmark
Mining a Whole Lot of Data and Investigating Engraftment Dynamics for Optimized Strain Selection and Understanding Some of the Links Between Host, Engraftment and Clinical Response
Gustav Lindved, Clinical Microbiomics, Denmark
In silico Modelling Links Microbiome-derived Metabolites to Risk Factors for Alzheimer’s Disease
Tim Hensen, National University of Ireland, Ireland
Data-visualization with Relevance to Pro, Pre, Post & Other Biotics in the AI
Koen Venema, Wageningen Food & Biobased Research, Wageningen University & Research, the Netherlands
Welcome drink

Day 2 – 19.6.2024

9:00 - 9:50
9:00 - 9:50
9:50 - 10:10
10:10 - 10:30
10:30 - 10:50
10:50 - 11:20
11:20 - 12:20
12:20 - 13:00
12:20 - 12:40
12:40 - 13:00
13:00 - 13:15
13:15 - 14:15
14:15 - 14:50
14:15 - 14:35
14:35 - 14:50
14:50 - 15:30
14:50 - 15:10
15:10 - 15:30
15:30 - 16:20
15:30 - 15:50
15:50 - 16:05
16:05 - 16:20
16:20 - 16:50
16:50 - 18:50
16:50 - 17:40
17:40 - 18:30
18:30 - 18:50
18:50 - 19:30
18:50 - 19:10
19:10 - 19:30
20:00
Panorama Hall
Immunology Session
From Probiotics to Live Biotherapeutic Products: A Journey in Science and Innovation
Sin-Hyeog Im, ImmunoBiome Inc., South Korea
Postbiotics: A New Frontier for Healthcare
Maria Rescigno, Humanitas University, Italy
The Immunomodulatory Proteins of Different Species of Faecalibacterium
Jean-Marc Chatel, INRAE France, Human Nutrition, France
Market Developments – Challenges for Probiotic Products, Update for All the IPA Activity Since the New Scope Change
George Paraskevakos, IPA, Canada
Coffee Break
Latest Evidence on Lacidofil® Formula as an Effective Adjunct to Support Worldwide Helicobacter pylori Eradication Strategy
Marie-Laure Oula, Lallemand Health Solutions, R&D - Clinical Program, Canada
Immunology Session
Comparing Probiotics in Different Formats
Irina Spacova, IPA & University of Antwerp, Belgium
ISO Update
George Paraskevakos, IPA, Canada
Future of Probiotics and Prebiotics – Visions and Opportunities
Isabelle Guelinckx, ILSI Europe, n.a., Belgium
Lunch Break
Immunology Session
Exploring the Biocatalytic efficiency of Levansucrase Enzymes: Synthesizing Innovative Fructooligosaccharides and Fructans and Assessing their functional benefits
Salwa Karboune, McGill University, Faculty of Agricultural and Environmental Sciences, Canada
Enhancing Vaginal Microbiota by Probiotic Supplementation: Insights from a Clinical Trial in Post-menopausal Women
Franco Vicariotto, McGill University, Faculty of Agricultural and Environmental Sciences, Canada
Microvesicles
The Interaction between Bacteria-derived Membrane Vesicles and the Host Frank Stassen Maastricht University, Medical Microbiology, Netherlands
Extracellular Vesicles Derived from the Probiotic Propionibacterium freudenreichii Interact with Human Intestinal Epithelial Cells and Modulate the Inflammatory Response Juliana Guimaraes Laguna INRAE, Institut Agro- STLO- UMR1253, France
Beyond Gut
Soil Microbiome Health and Challenges Faced by our Civilization
Nina Vinot, Bioprox Healthcare, France
Lacticaseibacillus rhamnosus PB01 Oral Supplementation Improves Wound Closure Rate in a Diabetic Rat Model
Shaghayegh Hemmati, Aalborg University, Health Science and Technology Department, Denmark
In Vivo Synergistic Effects of Lacticaseibacillus paracasei 11w and Galactooligosaccharide on Psychobiotic and Antidiabetic Efficacy in Female Mice with High-fat Diet
Ashwinipriyadarshini Megur, Vilnius University, Biological models- Institute of Biochemistry- Life Sciences Center, Lithuania
Coffee Break
Regulatory Session
EU Feed Additive Authorization - the Role of the EU Commission
Tommaso Atzeni, DG SANTE, European Commission, Belgium
EFSA's Risk Assessment of Feed Additives - What's New?
Rosella Brozzi, (EFSA) FEEDCO Unit European Food Safety Authority (EFSA), Belgium
Regulatory Insights in Registration of Microbial Products Intended for Use in Feed & in Food
Mireia Romagosa, Argenta Global, Spain
Probiotic Applications
Latest Developments in the European Regulatory Framework for Microbiome-based Health Products
Céline Druart, PRI – European Microbiome Regulatory Expertise Center, Belgium
Advancing Microbiome Therapeutics: Genetically Engineering Probiotic Microbes for Enhanced Management of Metabolic Diseases
Karl Alex Hedin, The Novo Nordisk Foundation Center for Biosustainability, Sweden
Conference Dinner
9:00 - 10:55
9:00 - 9:40
9:40 - 10:00
10:00 - 10:20
10:20 - 10:40
10:40 - 10:55
10:55 - 11:25
11:25 - 11:55
11:55 - 12:10
11:55 - 12:10
12:10 - 13:10
12:10 - 12:50
12:50 - 13:10
13:10 - 14:10
14:10 - 16:25
14:10 - 14:25
14:25 - 14:40
14:40 - 14:55
14:55 - 15:10
15:10 - 15:25
15:25 - 15:40
15:40 - 15:55
15:55 - 16:10
16:10 - 16:25
16:25 - 16:55
16:55 - 19:10
16:55 - 17:10
17:10 - 17:25
17:25 - 17:40
17:40 - 17:55
17:55 - 18:10
18:10 - 18:25
18:25 - 18:40
18:45 - 18:55
18:55 - 19:10
Club A
Animal Health Symposium
THINK BEYOND OBVIOUS: Use of Exogenous Enzymes in Shaping Gut Microbiota in Monogastric Animals
Ajay Awati, EW Nutrition, UK
Fructophilic Lactic Acid Bacteria: Their Niche-Specific Adaptation and Practical Importance
Akihito Endo, Tokyo University of Agriculture, Japan
Lactococcus lactis Induces Trained Immunity in Non-immune Cells During Staphylococcus aureus Infection
Nadejda Berkova, INRAE National Research Institute for Agriculture- Food and the Environment, Institut Agro- STLO, France
Immunomodulatory and Gut-Protective Effects of a New Probiotic Feed Intended for Salmonids
Dagmar Mudroňová, University of Veterinary Medicine and Pharmacy, Slovakia
New Promising Probiotic Strains as Regulators of Microbiota and Growth Promoters in Poultry Diets
Iryna Matiukha, Ivan Franko National University of Lviv, Ukraine
Coffee Break
Bacillus Probiotics and Gut Microbiota in Animal Production: History and Current Changes
Tomohiro Hamaoka, Asahi Biosciences, USA
Animal Health Symposium
Definition of New Gut Health Biomarkers: Let the Microbes Speak
Nuria Vieco, Adisseo France S.A.S, European Laboratory of Innovation Science and Expertise ELISE, France
Antibiotics Produced by Gut Microbiota, Bacteriocins, Antimicrobials
Biotechnological Potential of Bacteriocinogenic Lactic Acid Bacteria is Objective, but Safety is the Priority
Svetoslav Todorov, Universidade Federal de Viçosa, Brasil
Food Biopreservation by Means of Bacteriophages, Phage Endolysins and Bacteriocins
Beatriz Martínez Fernández, The Dairy Research Institute of Asturias - IPLA, Spain
Lunch Break
Antibiotics Produced by Gut Microbiota, Bacteriocins, Antimicrobials
Reconstruction of the Human Gut-Liver-Brain Axis Reveals Short-Chain Fatty Acids as a Double-Edged Sword in the Progression of Inflammatory Bowel Disease and Neurodegenerative Disorders.
Martin Trapecar, The Johns Hopkins University School of Medicine, Massachusetts, USA
Set-up of Immunocompetent Mid-throughput Gut-on-a-Chip Model to Study Host - Microbiota Interaction
Ilia Belotserkovsky, BIOASTER, Microbiota Program, France
Modulation of the Gut Microbiome and Firmicutes phylum Reduction by a Nutraceutical Blend in the Obesity Mouse Model and Overweight Humans: A Double-blind Clinical Trial
Ana Flavia Pessoa, Faculdade de Medicina da Universidade de São Paulo FMUSP, Brazil
Lactiplantibacillus plantarum WCFS1®: Deciphering the Impact of an Efficacious Probiotic Formulation on the Intestinal Microbiome and on Weight Management
Émilie Desfossés-Foucault, Biena inc., Canada
Modeling the Effects of Prebiotic Interventions on Luminal and Mucosa-associated Gut Microbiota with and without Clostridioides difficile Challenge in Vitro
Maria Wiese, TNO, Microbiology and Systems Biology, Netherlands
Lactiplantibacillus plantarum as a Tool to Enhance Fermented Foods Functionality: an Insight into Anti-inflammatory Activity and Gut Modulation
Roberta Prete, University of Teramo, Dept. of Bioscience and Technology for Food- Agriculture and Environment, Italy
Is Kombucha a Probiotic? A Review of the Clinical Trials Evidence in Humans
Julie Kapp, University of Missouri, Public Health, Columbia, USA
Biofilm Formation and Biofilm Inhibition Properties of Lactic Acid Bacteria
Shakhlo Miralimova, Institute of microbiology of Academy of Sciences of Uzbekistan, Uzbekistan
Microbial Balance in the Liver Saga: Adlercreutzia equolifaciens DSM 19450 as the Heroic Anti-Inflammatory Bacterium in the War Against MASLD
Sebastian Burz, Université Paris-Saclay- INRAE- AgroParisTech-, MGP- MetaGenoPolis- Micalis Institute, France
Coffee Break
Antibiotics Produced by Gut Microbiota, Bacteriocins, Antimicrobials
Fermented Beetroot Prevents Prediabetes in High-Fat-Fed Mice and Causes Similar Changes in Prediabetic Mice and Human Gut Microbiota
Eric Daliri, Vilnius University, Department of Biological Models- Institute of Biochemistry, Lithuania
Yoghurt Supplementation Might Improve Gut Health and Support Growth in Malnourished Infants: A Pilot Randomised Controlled Trial in Dhaka’s Slums
Kaniz Jannat, Western Sydney University, School of Health Sciences, Australia
Impact of Xenobiotics on Human Gut Microbiota: Acute and Prolonged Exposure Studies Using the Simplified Human Gut Microbiota Model (SIHUMIx)
Victor Castañeda-Monsalve, Helmholtz Centre for Environmental Research (UFZ, Germany
Lactobacillus Regulates IFNg in Response to Psychological Stress: A Study of the Altered Schaedler Flora
Andrea Merchak, University of Florida, Neuroscience, USA
The Impact of an Anti-inflammatory Probiotic Supplementation on Cognitive Functioning in the Elderly Population – the Moderating Role of the Dietary Pattern - Study Protocol
Maria Kossowska, SWPS University, Psychology, Poland
Unveiling Nature's Therapeutic Elixir: Harnessing the Power of Probiotic-Fermented Hemp Seeds as a Functional Food Ingredient for Alleviating Inflammatory and Immune Diseases: An Untargeted Metabolomics Perspective
Lingyue Shan, Kangwon National University, Food Science and Biotechnology, Korea Republic of
Development of a Machine Learning Algorithm for the Identification of Probiotic Organisms from Whole Genome Sequences
Arjun Ok, Indian Institute of Technology Mandi, School of Biosciences and Bioengineering, India
From Static in Vitro Models to a Novel Dynamic 3D Model of the Human Gut Microbiota
Marco Calvigioni, University of Pisa, Translational Research and New Technologies in Medicine and Surgery, Italy
Highly Conserved Bifidobacteria in the Human Gut: Bifidobacterium Longum Subsp. Longum as a Potential Modulator of Elderly Innate Immunity
Giulia Longhi, Microbiome Research Hub, Department of Chemistry- Life Sciences and Environmental Sustainability, Italy

Day 3 – 20.6.2024

9:00 - 10:55
9:00 - 9:20
9:20 - 9:40
9:40 - 10:00
10:00 - 10:20
10:20 - 10:40
10:40 - 10:55
10:55 - 11:25
11:25 - 13:00
11:25 - 11:35
11:35 - 11:55
11:55 - 12:15
12:15 - 12:30
12:30 - 12:45
12:45 - 13:00
13:00 - 14:00
14:00 - 15:50
14:00 - 14:20
14:20 - 14:35
14:35 - 14:50
14:50 - 15:05
15:05 - 15:20
15:20 - 15:35
15:35 - 15:50
15:50 - 16:20
16:20 - 17:20
16:20 - 16:35
16:35 - 16:50
16:50 - 17:05
17:05 - 17:20
17:20 - 17:40
17:40
Panorama Hall
Industry Session - IPA
Probiotics Production Technology
George Paraskevakos, IPA, Canada
FMCG Gurus: Evolving Trends in the Biotics Market
Will Cowling, FMCG Gurus, UK
Customized Numbers for All E-commerce Biotics
Ewa Hudson, Lumina Intelligence, UK
Production: Alternative Count, Methods, Frontiers
Marie-Eve Boyte, United States Pharmacopeia (USP) - USA
Flow Cytometry - Opportunities, Challenges and Full Adoption
Marco Pane, Probiotical SpA, Italy
The Best of Both Worlds: Combining Fluorescence In Situ Hybridization (FISH) and Digital PCR (dPCR) for Advanced Microbiome Analysis
Jiri Snaidr, Vermicon AG, Solutions for Microbiology, Germany
Coffee Break
Postbiotics are (Not) Dead
What industry Thinks Postbiotics Are? Survey
George Paraskevakos, IPA, Canada
Elvis Isn't Dead, and Neither Are Postbiotics
Arthur C. Ouwehand, IFF, Finland
How Do You Identify a Postbiotic
Simone Guglielmetti, Università degli Studi di Milano-Bicocca, Italy
Antioxidant Mechanisms of Latilactobacillus sakei F1 from Kimchi and Its Potential as a Postbiotic
Thi Thu Hao Van, RMIT University, Biosciences and Food Technology, Australia
Next Generation of Prebiotics: Postbiotics of Condensed Tannins Have the Potential to Reduce the Risk of Nonalcoholic Fatty Liver Disease (NAFLD)
H.P. Vasantha Rupasinghe, Dalhousie University, Plant- Food- and Environmental Sciences, Canada
Revealing the Functional Mediators of Immunomodulatory Postbiotics Using Bioactivity-guided Chromatographic Fractionation and Untargeted Metabolomics
Alessandro Bernardinello, HUMANITAS UNIVERISTY, Department of Biomedical Sciences, Italy
Lunch Break
Postbiotics are (Not) Dead
CMO Companies: How do they Produce and Control Quality of Probiotic Strains?
Aurora Meucci, SACCO-System, Italy
Unleashing Nutrient-Microbe Synergies: Synbiotic Bacillus megaterium and Omega-3 Salt Compositions are Novel Leads for Resolution Medicine
Bodo Speckmann, Evonik, Germany
Human Gut-associated Bifidobacterium species salvage exogenous indole, a uremic toxin precursor, to synthesize indole-3-lactic acid via tryptophan metabolism.
Cheng Chung Yong, Morinaga Milk Industry Co. Ltd., Next Generation Science Institute, Japan
Improving Adhesion Activity of Soy Dough against Enterotoxigenic Escherichia coli through Fermentation with Exopolysaccharides-producing Lactic Acid Bacteria
Theodorus Eko Pramudito, Wageningen University, the Netherlands
The Effect of Two Probiotics on the Improvement of Non Alcoholic Fatty Liver Disease
Sumin Kang, Hanyang University, Department of Food and Nutrition, South Korea
Enhancing Vitamin K Status Through Probiotic Supplementation: A Double-Blinded Randomized Clinical Trial Investigating Menaquinone-Producing Bacteria in Adults at Elevated Cardiovascular Risk
Maria Stolaki, Winclove Probiotics, PCD, Netherlands
In Vitro and in Silico Analysis of Probiotic Attributes and Safety Assessment of a Set of Bifidobacterium longum
Peter Myintzaw, Teagasc Food Research Centre, Food Biological Science, Ireland
Coffee Break
Postbiotics are (Not) Dead
Neuroimaging Reveals Oral Probiotic Intervention Effects on Brain Structure and Function via the Gut-Brain Axis in Human Adults
Julia Rode, Örebro University, School of Medical Sciences, Sweden
StrainInSight: a Unique Private Strain Collection and Innovative Tools to Facilitate Novel Strain Discovery
Eliza Depoorter, LM-UGent - StrainInSight, Biochemistry and Microbiology, Belgium
Nutraceutical Mico-Mama 2.0 Mushrom Extract Shows Prebiotic Activity in an in Vitro Model Using Microbiota from Breast Cancer Patients
Radu Ghemis, Acondicionamiento Tarrasense LEITAT, Applied Microbiology and Biotechnologies, Spain
Stimulation of Growth and Metabolite Production by Probiotic Bacteria Using Olive Polyphenols and Low Intensity Electric Current
Ioannis Giavasis, University of Thessaly, Food Science and Nutrition, Greece
Young Scientist Award and Best Poster Award
Farewell drink